COMPARE THE EFFECT OF LOCAL APPLICATION OF MANJISHTHADI PLASTER AND BELLADONNA PLASTER IN THE MANAGEMENT OF ANKLE SPRAIN AND WRIST SPRAIN

A COMPARATIVE STUDY OF MANJISHTHADI PLASTER WITH BELLADONNA PLASTER IN THE MANAGEMENT OF RUJAKARMARMAKSHATA OF GULPHA AND MANIBANDH SANDHI (ANKLE SPRAIN AND WRIST SPRAIN)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/026973

Enrollment

Registered

2020-08-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S635- Other and unspecified sprain of wrist Health Condition 2: S934- Sprain of ankle

Interventions

Intervention1: MANJISHTHADI PLASTER: MANJISHTHADI PLASTER ON ALTERNATE DAY FOR 15 DAYS APPLIED ON AFFECTED PART Control Intervention1: BELLADONNA PLASTER: BELLADONNA PLASTER ON ALTERNATE DAY FOR 15 DA

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WITH CLASSICAL SIGNS AND SYMPTOMS OF RUJAKARMARMAKSHATA PATIENTS OF FIRST AND SECOND GRADE OF SPRAIN

Exclusion criteria

Exclusion criteria: PATIENTS BELOW 18 YEARS AND ABOVE 60 YEARS PATIENTS OF THIRD GRADE OF SPRAIN PATIENTS WITH PATHOLOGICAL FRACTURE AND OPEN WOUND LOCALIZED DEFECTS LIKE METASTATIC TUMOR ACQUIRED ANOMALIES LIKE OSTEOMYELITIS AND RHEUMATOID ARTHRITIS COAGULOPATHY LIKE HEMOPHILIA FRACTURE WITH COMPLICATIONS LIKE INJURY TO THE BLOOD VESSELS OR NERVES

Design outcomes

Primary

Measure	Time frame
EFFECTS OF BOTH THERAPIES ON PAIN, SWELLING, MOVEMENTS AND TENDERNESSTimepoint: 15 DAYS	—

Secondary

Measure	Time frame
TO STOP RECURRENCE AND IMPROVE THE QUALITY OF LIFETimepoint: 10 WEEKS	—

Countries

India

Contacts

Public ContactDR HARSHIT SHAH

GOVERNMENT AKHANDANAND AYURVED COLLEGE

sejharsh@gmail.com9824068760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026